{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:37:23Z","timestamp":1768995443813,"version":"3.49.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30972754"],"award-info":[{"award-number":["30972754"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871659"],"award-info":[{"award-number":["81871659"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01253","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T13:50:40Z","timestamp":1593784240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Methadone Inhibits Viral Restriction Factors and Facilitates HIV Infection in Macrophages"],"prefix":"10.3389","volume":"11","author":[{"given":"Mei-Rong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di-Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Jie","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Rong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2105\/AJPH.91.7.1060","article-title":"HIV in the United States at the turn of the century: an epidemic in transition","volume":"91","author":"Karon","year":"2001","journal-title":"Am J Public Health."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/01.aids.0000327439.20914.33","article-title":"The role of harm reduction in controlling HIV among injecting drug users","volume":"22","author":"Wodak","year":"2008","journal-title":"AIDS."},{"key":"B3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fpubh.2019.00327","article-title":"The decade-long chinese methadone maintenance therapy yields large population and economic benefits for drug users in reducing harm, HIV and HCV disease burden","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","article-title":"Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy","volume":"286","author":"Hogg","year":"2001","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/09540120412331305098","article-title":"Terry Beirn Community Programs for clinical research on: quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence","volume":"17","author":"Mannheimer","year":"2005","journal-title":"AIDS Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00042560-200109010-00008","article-title":"Trust and the acceptance of and adherence to antiretroviral therapy","volume":"28","author":"Altice","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/aje\/kwj059","article-title":"Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy","volume":"163","author":"Lucas","year":"2006","journal-title":"Am J Epidemiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00126334-200107010-00006","article-title":"Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection","volume":"27","author":"Lucas","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1086\/378703","article-title":"Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy","volume":"188","author":"Wood","year":"2003","journal-title":"J Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","volume":"105","author":"Uhlmann","year":"2010","journal-title":"Addiction"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/j.1360-0443.2008.02323.x","article-title":"The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study","volume":"103","author":"Roux","year":"2008","journal-title":"Addiction."},{"key":"B13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy","volume":"84","author":"Palepu","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"B14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00213-002-1027-0","article-title":"High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans","volume":"161","author":"Donny","year":"2002","journal-title":"Psychopharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0165-5728(97)00224-5","article-title":"Opiates as potential cofactors in progression of HIV-1 infections to AIDS","volume":"83","author":"Donahoe","year":"1998","journal-title":"J Neuroimmunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infection","volume":"83","author":"Risdahl","year":"1998","journal-title":"J Neuroimmunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1086\/433175","article-title":"The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations","volume":"41","author":"Kapadia","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0042-6822(03)00015-1","article-title":"\u03bc-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication","volume":"309","author":"Steele","year":"2003","journal-title":"Virology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0165-5728(95)00159-X","article-title":"Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H","volume":"64","author":"Alicea","year":"1996","journal-title":"J Neuroimmunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.4049\/jimmunol.169.7.3589","article-title":"Morphine regulates gene expression of - and -chemokines and their receptors on Astroglial cells via the opioid receptor","volume":"169","author":"Mahajan","year":"2002","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1086\/520093","article-title":"Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication","volume":"196","author":"Li","year":"2007","journal-title":"J Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2008.04.026","article-title":"Morphine suppresses intracellular interferon-alpha expression in neuronal cells","volume":"199","author":"Wan","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/338011","article-title":"Methadone enhances human immunodeficiency virus infection of human immune cells","volume":"185","author":"Li","year":"2002","journal-title":"J Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jneuroim.2013.07.012","article-title":"mu opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes","volume":"263","author":"Borner","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2012.10.015","article-title":"Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function","volume":"255","author":"Kafami","year":"2013","journal-title":"J Neuroimmunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0002-9343(91)80155-F","article-title":"Immune function and anti-HTLV-I\/II status in anti-HIV-1-negative intravenous drug users receiving methadone","volume":"90","author":"Klimas","year":"1991","journal-title":"Am J Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1189\/jlb.0312146","article-title":"CD56+ T cells inhibit HIV-1 infection of macrophages","volume":"92","author":"Hou","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000490586","article-title":"Human cervical epithelial cells release antiviral factors and inhibit HIV replication in macrophages","volume":"11","author":"Xu","year":"2019","journal-title":"J Innate Immun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/87979","article-title":"A quantitative assay for HIV DNA integration in vivo","volume":"7","author":"Butler","year":"2001","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"19042","DOI":"10.1074\/jbc.M114.559831","article-title":"Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry","volume":"289","author":"Jin","year":"2014","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1128\/JVI.66.3.1321-1328.1992","article-title":"Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle","volume":"66","author":"Shirazi","year":"1992","journal-title":"J Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0952-7915(01)00305-3","article-title":"The interferon-alpha\/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors","volume":"14","author":"Taniguchi","year":"2002","journal-title":"Curr Opin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jlb.56.3.358","article-title":"Role of endogenous interferon-beta in the restriction of HIV replication in human monocyte\/macrophages","volume":"56","author":"Gessani","year":"1994","journal-title":"J Leukoc Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu Rev Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nri3295","article-title":"Evolutionary conflicts between viruses and restriction factors shape immunity","volume":"12","author":"Duggal","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/JLB.3MR0717-307R","article-title":"Interferons and beyond: Induction of antiretroviral restriction factors","volume":"103","author":"Hotter","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/nm1639","article-title":"Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes","volume":"13","author":"Huang","year":"2007","journal-title":"Nat Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1182\/blood-2008-09-175000","article-title":"Cellular microRNA expression correlates with susceptibility of monocytes\/macrophages to HIV-1 infection","volume":"113","author":"Wang","year":"2009","journal-title":"Blood."},{"key":"B39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J Addict Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr Serv"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrd897","article-title":"Pharmacotherapy of addictions","volume":"1","author":"Kreek","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"B43","doi-asserted-by":"publisher","first-page":"CD002209","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"8","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2353\/ajpath.2008.070971","article-title":"Methamphetamine enhances HIV infection of macrophages","volume":"172","author":"Liang","year":"2008","journal-title":"Am J Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.lfs.2010.09.019","article-title":"Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells","volume":"88","author":"Nair","year":"2011","journal-title":"Life Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2353\/ajpath.2010.090953","article-title":"Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys","volume":"177","author":"Marcondes","year":"2010","journal-title":"Am J Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1089\/aid.2008.0282","article-title":"Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication","volume":"25","author":"Toussi","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/j.1530-0277.2002.tb02496.x","article-title":"Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes","volume":"26","author":"Wang","year":"2002","journal-title":"Alcohol Clin Exp Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fmicb.2015.01230","article-title":"Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages","volume":"6","author":"Wang","year":"2015","journal-title":"Front Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/jim-50-06-03","article-title":"Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor","volume":"50","author":"Guo","year":"2002","journal-title":"J Investig Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3389\/fimmu.2019.02601","article-title":"Morphine withdrawal enhances HIV infection of macrophages","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/CDLI.7.1.96-100.2000","article-title":"Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients","volume":"7","author":"Nair","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1359-6101(00)00033-2","article-title":"Human immunodeficiency virus type-1 and chemokine beyond competition for common cellular receptors","volume":"12","author":"Stantchev","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr Opin Virol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e31167","DOI":"10.1371\/journal.pone.0031167","article-title":"Morphine suppresses IFN signaling pathway and enhances AIDS virus infection","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE."},{"key":"B56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tibs.2007.01.004","article-title":"APOBEC-mediated viral restriction: not simply editing?","volume":"32","author":"Holmes","year":"2007","journal-title":"Trends Biochem Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature."},{"key":"B58","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature03493","article-title":"Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells","volume":"435","author":"Chiu","year":"2005","journal-title":"Nature."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1128\/JVI.03730-14","article-title":"Contribution of MxB oligomerization to HIV-1 capsid binding and restriction","volume":"89","author":"Buffone","year":"2015","journal-title":"J Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nature06205","article-title":"Interferon modulation of cellular microRNAs as an antiviral mechanism","volume":"449","author":"Pedersen","year":"2007","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1002937","DOI":"10.1371\/journal.ppat.1002937","article-title":"A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages","volume":"8","author":"Swaminathan","year":"2012","journal-title":"PLoS Pathog"},{"key":"B62","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3389\/fmicb.2015.00967","article-title":"Interaction of drugs of abuse and microRNA with HIV: a brief review","volume":"6","author":"Pilakka-Kanthikeel","year":"2015","journal-title":"Front Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"16334","DOI":"10.1074\/jbc.M109.011601","article-title":"MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN)","volume":"284","author":"Martinez-Nunez","year":"2009","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1749-6632.2000.tb05180.x","article-title":"Activation of an effector immediate-early gene arc by methamphetamine","volume":"914","author":"Yamagata","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bbi.2011.12.010","article-title":"Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages","volume":"26","author":"Franchi","year":"2012","journal-title":"Brain Behav Immun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav Immun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.intimp.2018.11.047","article-title":"Methadone therapy modulate the dendritic cells of heroin addicts","volume":"66","author":"Akbari","year":"2019","journal-title":"Int Immunopharmacol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T13:50:45Z","timestamp":1593784245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2020.01253"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01253","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"article-number":"1253"}}